Harvard Bioscience Inc
Research Harvard Bioscience Inc (HBIO) on Bullrun: market cap USD 27.62M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHBIO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 27.62M
- Financial periodFY2025
- RevenueUSD 86.55M
- Revenue growth-8.1%
- Net income-USD 56.70M
- Free cash flowUSD 5.47M
- Gross margin57.7%
Valuation Snapshot
latest market cap is USD 27.62M.
About Harvard Bioscience Inc
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research;
Frequently asked questions
What is Harvard Bioscience Inc's market cap?
Harvard Bioscience Inc's market capitalization is USD 27.62M.
What does Harvard Bioscience Inc do?
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.